BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
2817713
Number of visits today
988
Number of downloads
2067123
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Chaudhuri A, Kumar DN, Dehari D, Singh S, Kumar P, Bolla PK, Kumar D, Agrawal AK. Emergence of Nanotechnology as a Powerful Cavalry against Triple-Negative Breast Cancer (TNBC). Pharmaceuticals 2022;15:542. [DOI: 10.3390/ph15050542] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Kumar H, Gupta NV, Jain R, Madhunapantula SV, Babu CS, Kesharwani SS, Dey S, Jain V. A review of biological targets and therapeutic approaches in the management of triple-negative breast cancer. J Adv Res 2023:S2090-1232(23)00056-5. [PMID: 36791960 DOI: 10.1016/j.jare.2023.02.005] [Reference Citation Analysis]
2 Han R, Yang H, Ling C, Lu L. Tiliroside suppresses triple-negative breast cancer as a multifunctional CAXII inhibitor. Cancer Cell Int 2022;22:368. [PMID: 36424626 DOI: 10.1186/s12935-022-02786-6] [Reference Citation Analysis]
3 Chaudhuri A, Ramesh K, Kumar DN, Dehari D, Singh S, Kumar D, Agrawal AK. Polymeric micelles: A novel drug delivery system for the treatment of breast cancer. Journal of Drug Delivery Science and Technology 2022;77:103886. [DOI: 10.1016/j.jddst.2022.103886] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Liu J, Tang Y, Li Y, Hu X, Huang S, Xu W, Hao X, Zhou M, Wu J, Xiang D. Paclitaxel-loaded hybrid exosome for targeted chemotherapy of triple-negative breast cancer.. [DOI: 10.21203/rs.3.rs-2144965/v1] [Reference Citation Analysis]
5 Chaudhuri A, Kumar DN, Shaik RA, Eid BG, Abdel-Naim AB, Md S, Ahmad A, Agrawal AK. Lipid-Based Nanoparticles as a Pivotal Delivery Approach in Triple Negative Breast Cancer (TNBC) Therapy. Int J Mol Sci 2022;23:10068. [PMID: 36077466 DOI: 10.3390/ijms231710068] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Kumar DN, Chaudhuri A, Dehari D, Shekher A, Gupta SC, Majumdar S, Krishnamurthy S, Singh S, Kumar D, Agrawal AK. Combination Therapy Comprising Paclitaxel and 5-Fluorouracil by Using Folic Acid Functionalized Bovine Milk Exosomes Improves the Therapeutic Efficacy against Breast Cancer. Life (Basel) 2022;12:1143. [PMID: 36013322 DOI: 10.3390/life12081143] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345